The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Bolotina L.V.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdravsotsrazvitiia Rossii

Paĭchadze A.A.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena Minzdrava Rossii

Drug therapy for primitive neuroectodermal tumor

Authors:

Bolotina L.V., Paĭchadze A.A.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2013;2(2): 54‑57

Read: 1853 times

Download PDF (RU)
Contact the author
Table of contents

DRUG THERAPY FOR PRIMITIVE NEUROECTODERMAL TUMOR
DRUG THERAPY FOR PRIMITIVE NEUROECTODERMAL TUMOR

To cite this article:

Bolotina LV, Paĭchadze AA. Drug therapy for primitive neuroectodermal tumor. P.A. Herzen Journal of Oncology. 2013;2(2):54‑57. (In Russ.)

Подписка 2026 Онкология. Журнал им. П.А. Герцена (P.A. Herzen Journal of Oncology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Possibilities of drug treatment for pseudomyxoma peri­tonei of appe­ndiceal origin. P.A. Herzen Journal of Onco­logy. 2025;(6):59-64
Endo­thelial function in patients with heart failure with preserved ejection fraction unde­rgoing multicomponent drug therapy. Russian Cardiology Bulletin. 2025;(4-2):135-144
Abstract:

The paper describes the experience of successful treatment in a 38-year-old patient for disseminated primitive neuroectodermal tumor (PNET) of soft tissues in the left neck with metastases to the lung and pleura. The Russian literature has a limited number of publications on this topic. Our clinical case will help a wide circle of practicing oncologists suspecting PNET to choose an optimal package of diagnostic and medical measures in each individual case.

Keywords:

drug therapy
polychemotherapy
primitive neuroectodermal tumor

Authors:

Bolotina L.V.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdravsotsrazvitiia Rossii

Paĭchadze A.A.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena Minzdrava Rossii

Close metadata

References:

  1. Horowitz M.E., Malawer M.M., Woo S.Y., Hicks M.J. Ewing's sarcoma of bone. In: Pizzo P.A., Poplack D.G., eds. Principles and practice of pediatric oncology. 3rd ed. Philadelphia: Lippincott-Raven; 1997: 831-63.
  2. de Vita V., Hellmann S., Rosenberg S. Cancer: Principles and practice of oncology. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2001.
  3. de Alava E., Kawai A., Healey J.H., Fligman I., Meyers P.A., Huvos A.G. et al. EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. J. Clin. Oncol. 1998;16 (4): 1248-55.
  4. Smirnov A.V. Immunogistokhimiya v diagnostike opukholei myagkikh tkanei. V kn.: Petrov S.V., Raikhlin N.T., red. Rukovodstvo po immunogistokhimicheskoi diagnostike opukholei cheloveka. Kazan': Titul; 2004.
  5. Semenova A.I. Sarkoma Yuinga i perifericheskie primitivnye neiroektodermal'nye opukholi (klinika, diagnostika, lechenie). Prakticheskaya onkologiya. 2005; 6 (4): 234-9.
  6. Rosito P., Mancini A.F., Rondelli R., Abate M.E., Pession A., Bedei L. et al. Italian cooperative study for the treatment of children and young adults with localized Ewing sarcoma of bone. Cancer. 1999; 86 (3): 421-8.
  7. Smith M.A., Ungerleider R.S., Horowitz M.E., Simon R. Influence of doxorubicin dose intensity on response and outcome for patients with osteogenic sarcoma and Ewing's sarcoma. J. Natl. Cancer Inst. 1991; 83 (20): 1460-70.
  8. Grier H.E., Krailo M.D., Tarbell N.J. et al. Addition of ifosfamide and etoposide to vincristine, cyclophosphamide, adriamycin and actinomycin improves outcome in non-metastatic Ewing's and PNET: update of CCG/POG study. Med. Pediatr. Oncol. 1996; 27: 259.
  9. Wexler L.H., DeLaney T.F., Tsokos M., Avila N., Steinberg S.M., Weaver-McClure L. et al. Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors. Cancer. 1998; 78: 901-911.
  10. Barker L.M., Pendergrass T.W., Sanders J.E., Hawkins D.S. Survival after recurrence of Ewing's sarcoma family of tumors. J. Clin. Oncol. 2005; 23 (19): 4354-62.
  11. Paulussen M., Ahrens S., Burdach S., Craft A., Dockhorn-Dworniczak B., Dunst J. et al. Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. Ann. Oncol. 1998; 9 (3): 275-81.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.